top of page

Announcements

2023

Viscera Labs Announces Receipt of Issue Notification from the USPTO

Viscera Labs Announces the Completion of the Preclinical Evaluation of VL-001

2022

Viscera Labs Announces Receipt of Issue Notification from the USPTO

2020

Viscera Labs Announces the Preclinical Investigation of Colesevelam Targeted Delivery 

View PDF

bottom of page